Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma.

Enqvist M, Jacobs B, Junlén HR, Schaffer M, Melén CM, Friberg D, Wahlin BE, Malmberg KJ.

Front Immunol. 2019 Sep 12;10:2085. doi: 10.3389/fimmu.2019.02085. eCollection 2019.

2.

Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.

Cornillet M, Jansson H, Schaffer M, Hertwig L, Berglin L, Zimmer CL, Johansson H, Ellis E, Isaksson B, Gonzalez-Galarza FF, Middleton D, Malmberg KJ, Sparrelid E, Björkström NK.

Gastroenterology. 2019 Oct;157(4):1067-1080.e9. doi: 10.1053/j.gastro.2019.06.023. Epub 2019 Jun 21.

PMID:
31229495
3.

Multilevel fine-scale diversity challenges the 'cryptic species' concept.

Korshunova T, Picton B, Furfaro G, Mariottini P, Pontes M, Prkić J, Fletcher K, Malmberg K, Lundin K, Martynov A.

Sci Rep. 2019 May 1;9(1):6732. doi: 10.1038/s41598-019-42297-5.

4.

Remodeling of secretory lysosomes during education tunes functional potential in NK cells.

Goodridge JP, Jacobs B, Saetersmoen ML, Clement D, Hammer Q, Clancy T, Skarpen E, Brech A, Landskron J, Grimm C, Pfefferle A, Meza-Zepeda L, Lorenz S, Wiiger MT, Louch WE, Ask EH, Liu LL, Oei VYS, Kjällquist U, Linnarsson S, Patel S, Taskén K, Stenmark H, Malmberg KJ.

Nat Commun. 2019 Jan 31;10(1):514. doi: 10.1038/s41467-019-08384-x.

5.

50 years of research sparked by Atkinson and Shiffrin (1968).

Malmberg KJ, Raaijmakers JGW, Shiffrin RM.

Mem Cognit. 2019 May;47(4):561-574. doi: 10.3758/s13421-019-00896-7.

PMID:
30689198
6.

Induction of the BIM Short Splice Variant Sensitizes Proliferating NK Cells to IL-15 Withdrawal.

Jacobs B, Pfefferle A, Clement D, Berg-Larsen A, Saetersmoen ML, Lorenz S, Wiiger MT, Goodridge JP, Malmberg KJ.

J Immunol. 2019 Feb 1;202(3):736-746. doi: 10.4049/jimmunol.1801146. Epub 2018 Dec 21.

PMID:
30578306
7.

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting.

De Santis F, Del Vecchio M, Castagnoli L, De Braud F, Di Cosimo S, Franceschini D, Fucà G, Hiscott J, Malmberg KJ, McGranahan N, Pietrantonio F, Rivoltini L, Sangaletti S, Tagliabue E, Tripodo C, Vernieri C, Zitvogel L, Pupa SM, Di Nicola M.

Cytokine Growth Factor Rev. 2018 Dec;44:1-10. doi: 10.1016/j.cytogfr.2018.10.005. Epub 2018 Oct 30.

PMID:
30393044
8.

Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.

Saetersmoen ML, Hammer Q, Valamehr B, Kaufman DS, Malmberg KJ.

Semin Immunopathol. 2019 Jan;41(1):59-68. doi: 10.1007/s00281-018-0721-x. Epub 2018 Oct 25. Review.

PMID:
30361801
9.

Effect of anthocyanins on lipid oxidation and microbial spoilage in value-added emulsions with bilberry seed oil, anthocyanins and cold set whey protein hydrogels.

Svanberg L, Malmberg K, Gustinelli G, Öhgren C, Persson I, Brive L, Wassén S.

Food Chem. 2019 Jan 30;272:273-278. doi: 10.1016/j.foodchem.2018.06.064. Epub 2018 Jun 15.

10.

The effect of perceptual information on output interference.

Chen S, Malmberg KJ, Prince M, Peckoo S, Criss AH.

Psychon Bull Rev. 2019 Feb;26(1):269-278. doi: 10.3758/s13423-018-1521-y.

PMID:
30120704
11.

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.

Schrieks IC, Nozza A, Stähli BE, Buse JB, Henry RR, Malmberg K, Neal B, Nicholls SJ, Rydén L, Mellbin L, Svensson A, Wedel H, Weichert A, Lincoff AM, Tardif JC, Grobbee DE, Schwartz GG.

Diabetes Care. 2018 Aug;41(8):1792-1800. doi: 10.2337/dc18-0158. Epub 2018 Jun 14.

12.

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.

Stähli BE, Nozza A, Schrieks IC, Buse JB, Malmberg K, Mellbin L, Neal B, Nicholls SJ, Rydén L, Svensson A, Wedel H, Weichert A, Lincoff AM, Grobbee DE, Tardif JC, Schwartz GG.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2522-2533. doi: 10.1210/jc.2017-02772.

13.

First true brackish-water nudibranch mollusc provides new insights for phylogeny and biogeography and reveals paedomorphosis-driven evolution.

Korshunova T, Lundin K, Malmberg K, Picton B, Martynov A.

PLoS One. 2018 Mar 14;13(3):e0192177. doi: 10.1371/journal.pone.0192177. eCollection 2018.

14.

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.

Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ.

Cancer Immunol Res. 2018 Apr;6(4):467-480. doi: 10.1158/2326-6066.CIR-17-0207. Epub 2018 Feb 19.

15.

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.

Björklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, Watz E, Wikström K, Blomberg P, Wahlin BE, Palma M, Hansson L, Ljungman P, Hellström-Lindberg E, Ljunggren HG, Malmberg KJ.

Clin Cancer Res. 2018 Apr 15;24(8):1834-1844. doi: 10.1158/1078-0432.CCR-17-3196. Epub 2018 Feb 14.

16.

Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.

Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, Morocutti G, Ferri M, Cavallini C, Eijkemans MJ, Stähli BE, Schrieks IC, Toyama T, Lambers Heerspink HJ, Malmberg K, Schwartz GG, Lincoff AM, Ryden L, Tardif JC, Grobbee DE.

Diab Vasc Dis Res. 2018 Jan;15(1):14-23. doi: 10.1177/1479164117735493. Epub 2017 Oct 20.

PMID:
29052439
17.

CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

Wagner JA, Rosario M, Romee R, Berrien-Elliott MM, Schneider SE, Leong JW, Sullivan RP, Jewell BA, Becker-Hapak M, Schappe T, Abdel-Latif S, Ireland AR, Jaishankar D, King JA, Vij R, Clement D, Goodridge J, Malmberg KJ, Wong HC, Fehniger TA.

J Clin Invest. 2017 Nov 1;127(11):4042-4058. doi: 10.1172/JCI90387. Epub 2017 Oct 3.

18.

Natural killer cell-mediated immunosurveillance of human cancer.

Malmberg KJ, Carlsten M, Björklund A, Sohlberg E, Bryceson YT, Ljunggren HG.

Semin Immunol. 2017 Jun;31:20-29. doi: 10.1016/j.smim.2017.08.002. Epub 2017 Sep 6. Review.

PMID:
28888619
19.

Bioinformatics Approaches to Profile the Tumor Microenvironment for Immunotherapeutic Discovery.

Clancy T, Dannenfelser R, Troyanskaya O, Malmberg KJ, Hovig E, Kristensen V.

Curr Pharm Des. 2017;23(32):4716-4725. doi: 10.2174/1381612823666170710154936. Review.

PMID:
28699527
20.

Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition.

Malmberg KJ, Sohlberg E, Goodridge JP, Ljunggren HG.

Immunogenetics. 2017 Aug;69(8-9):547-556. doi: 10.1007/s00251-017-1011-9. Epub 2017 Jul 11. Review.

21.

Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells.

Liu LL, Béziat V, Oei VYS, Pfefferle A, Schaffer M, Lehmann S, Hellström-Lindberg E, Söderhäll S, Heyman M, Grandér D, Malmberg KJ.

Cancer Immunol Res. 2017 Aug;5(8):654-665. doi: 10.1158/2326-6066.CIR-16-0296. Epub 2017 Jun 21.

22.

Release from output interference in recognition memory: A test of the attention hypothesis.

Criss AH, Salomão C, Malmberg KJ, Aue W, Kılıç A, Claridge M.

Q J Exp Psychol (Hove). 2018 May;71(5):1081-1089. doi: 10.1080/17470218.2017.1310265. Epub 2018 Jan 1.

PMID:
28351212
23.

Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.

Ritsinger V, Brismar K, Malmberg K, Mellbin L, Näsman P, Rydén L, Söderberg S, Tenerz Å, Norhammar A.

Diab Vasc Dis Res. 2017 Mar;14(2):77-87. doi: 10.1177/1479164116678156. Epub 2016 Dec 21.

PMID:
28185529
24.

Models that allow us to perceive the world more accurately also allow us to remember past events more accurately via differentiation.

Kılıç A, Criss AH, Malmberg KJ, Shiffrin RM.

Cogn Psychol. 2017 Feb;92:65-86. doi: 10.1016/j.cogpsych.2016.11.005. Epub 2016 Nov 28.

PMID:
27907808
25.

Class I HLA haplotypes form two schools that educate NK cells in different ways.

Horowitz A, Djaoud Z, Nemat-Gorgani N, Blokhuis J, Hilton HG, Béziat V, Malmberg KJ, Norman PJ, Guethlein LA, Parham P.

Sci Immunol. 2016 Sep;1(3). pii: eaag1672. doi: 10.1126/sciimmunol.aag1672. Epub 2016 Sep 9.

26.

Cognate HLA absence in trans diminishes human NK cell education.

Landtwing V, Raykova A, Pezzino G, Béziat V, Marcenaro E, Graf C, Moretta A, Capaul R, Zbinden A, Ferlazzo G, Malmberg KJ, Chijioke O, Münz C.

J Clin Invest. 2016 Oct 3;126(10):3772-3782. doi: 10.1172/JCI86923. Epub 2016 Aug 29.

27.

Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA.

Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J.

Oncoimmunology. 2016 Feb 18;5(5):e1138199. doi: 10.1080/2162402X.2016.1138199. eCollection 2016 May.

28.

Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.

Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, Oei VYS, Schaffer M, Taskén K, Ljunggren HG, Romagnani C, Trowsdale J, Malmberg KJ, Béziat V.

Cell Rep. 2016 May 3;15(5):1088-1099. doi: 10.1016/j.celrep.2016.04.005. Epub 2016 Apr 21.

29.

Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.

Malmberg K, Klynning C, Flöter-Rådestad A, Carlson JW.

Virchows Arch. 2016 Jun;468(6):707-13. doi: 10.1007/s00428-016-1928-7. Epub 2016 Mar 22.

PMID:
27003156
30.

Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Björklund AT, Clancy T, Goodridge JP, Béziat V, Schaffer M, Hovig E, Ljunggren HG, Ljungman PT, Malmberg KJ.

J Immunol. 2016 Feb 1;196(3):1400-11. doi: 10.4049/jimmunol.1501434. Epub 2016 Jan 8.

31.

Harnessing adaptive natural killer cells in cancer immunotherapy.

Liu LL, Pfefferle A, Yi Sheng VO, Björklund AT, Béziat V, Goodridge JP, Malmberg KJ.

Mol Oncol. 2015 Dec;9(10):1904-17. doi: 10.1016/j.molonc.2015.10.001. Epub 2015 Oct 20. Review.

32.

Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients.

Béziat V, Sleiman M, Goodridge JP, Kaarbø M, Liu LL, Rollag H, Ljunggren HG, Zimmer J, Malmberg KJ.

Front Immunol. 2015 Oct 6;6:507. doi: 10.3389/fimmu.2015.00507. eCollection 2015.

33.

Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome.

Sohlberg E, Pfefferle A, Andersson S, Baumann BC, Hellström-Lindberg E, Malmberg KJ.

Oncotarget. 2015 Oct 27;6(33):34178-90. doi: 10.18632/oncotarget.6213.

34.

Microchip-Based Single-Cell Imaging Reveals That CD56dimCD57-KIR-NKG2A+ NK Cells Have More Dynamic Migration Associated with Increased Target Cell Conjugation and Probability of Killing Compared to CD56dimCD57-KIR-NKG2A- NK Cells.

Forslund E, Sohlberg E, Enqvist M, Olofsson PE, Malmberg KJ, Önfelt B.

J Immunol. 2015 Oct 1;195(7):3374-81. doi: 10.4049/jimmunol.1500171. Epub 2015 Aug 28.

35.

Newtonian cell interactions shape natural killer cell education.

Goodridge JP, Önfelt B, Malmberg KJ.

Immunol Rev. 2015 Sep;267(1):197-213. doi: 10.1111/imr.12325. Review.

36.

Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes.

Erdmann E, Califf R, Gerstein HC, Malmberg K, Ruilope L, Schwartz GG, Wedel H, Volz D, Ditmarsch M, Svensson A, Bengus M.

Am Heart J. 2015 Jul;170(1):117-22. doi: 10.1016/j.ahj.2015.03.021. Epub 2015 Apr 2.

PMID:
26093872
37.

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation.

von Bahr L, Blennow O, Alm J, Björklund A, Malmberg KJ, Mougiakakos D, Le Blanc A, Oefner PJ, Labopin M, Ljungman P, Le Blanc K.

Bone Marrow Transplant. 2015 Sep;50(9):1217-23. doi: 10.1038/bmt.2015.123. Epub 2015 Jun 1.

PMID:
26030049
38.

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg KJ, Müller C, Battiwalla M, Gajewski J, Verneris MR, Ringdén O, Marino S, Davies S, Dehn J, Bornhäuser M, Inamoto Y, Woolfrey A, Shaw P, Pollack M, Weisdorf D, Milller J, Hurley C, Lee SJ, Hsu K.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1589-96. doi: 10.1016/j.bbmt.2015.05.002. Epub 2015 May 8.

39.

Coordinated expression of DNAM-1 and LFA-1 in educated NK cells.

Enqvist M, Ask EH, Forslund E, Carlsten M, Abrahamsen G, Béziat V, Andersson S, Schaffer M, Spurkland A, Bryceson Y, Önfelt B, Malmberg KJ.

J Immunol. 2015 May 1;194(9):4518-27. doi: 10.4049/jimmunol.1401972. Epub 2015 Mar 30.

40.

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, Han H, Chiang SC, Foley B, Mattsson K, Larsson S, Schaffer M, Malmberg KJ, Ljunggren HG, Miller JS, Bryceson YT.

Immunity. 2015 Mar 17;42(3):443-56. doi: 10.1016/j.immuni.2015.02.008.

41.

Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.

Ruilope L, Hanefeld M, Lincoff AM, Viberti G, Meyer-Reigner S, Mudie N, Wieczorek Kirk D, Malmberg K, Herz M.

BMC Nephrol. 2014 Nov 18;15:180. doi: 10.1186/1471-2369-15-180.

42.

Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.

Ritsinger V, Tanoglidi E, Malmberg K, Näsman P, Rydén L, Tenerz Å, Norhammar A.

Diab Vasc Dis Res. 2015 Jan;12(1):23-32. doi: 10.1177/1479164114551746. Epub 2014 Oct 13.

PMID:
25311248
43.

Role for early-differentiated natural killer cells in infectious mononucleosis.

Azzi T, Lünemann A, Murer A, Ueda S, Béziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, Münz C, Chijioke O, Nadal D.

Blood. 2014 Oct 16;124(16):2533-43. doi: 10.1182/blood-2014-01-553024. Epub 2014 Sep 9.

44.

The role of mnemonic processes in pure-target and pure-foil recognition memory.

Koop GJ, Criss AH, Malmberg KJ.

Psychon Bull Rev. 2015 Apr;22(2):509-16. doi: 10.3758/s13423-014-0703-5.

PMID:
25117090
45.

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Munneke JM, Björklund AT, Mjösberg JM, Garming-Legert K, Bernink JH, Blom B, Huisman C, van Oers MH, Spits H, Malmberg KJ, Hazenberg MD.

Blood. 2014 Jul 31;124(5):812-21. doi: 10.1182/blood-2013-11-536888. Epub 2014 May 22.

PMID:
24855210
46.

Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.

Ritsinger V, Malmberg K, Mårtensson A, Rydén L, Wedel H, Norhammar A.

Lancet Diabetes Endocrinol. 2014 Aug;2(8):627-33. doi: 10.1016/S2213-8587(14)70088-9. Epub 2014 May 13.

PMID:
24831989
47.

Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation.

Béziat V, Traherne J, Malmberg JA, Ivarsson MA, Björkström NK, Retière C, Ljunggren HG, Michaëlsson J, Trowsdale J, Malmberg KJ.

Eur J Immunol. 2014 Jul;44(7):2192-6. doi: 10.1002/eji.201444464. Epub 2014 May 7. No abstract available.

48.

Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals.

Lunemann S, Malone DF, Grabowski J, Port K, Béziat V, Bremer B, Malmberg KJ, Manns MP, Sandberg JK, Cornberg M, Ljunggren HG, Wedemeyer H, Björkström NK.

Gut. 2015 Mar;64(3):469-82. doi: 10.1136/gutjnl-2014-306767. Epub 2014 Apr 10.

PMID:
24721903
49.

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.

Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators.

JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.

PMID:
24682069
50.

Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity.

Bengnér M, Béziat V, Ernerudh J, Nilsson BO, Löfgren S, Wikby A, Malmberg KJ, Strindhall J.

Age (Dordr). 2014 Apr;36(2):571-82. doi: 10.1007/s11357-013-9587-y. Epub 2013 Sep 25.

Supplemental Content

Loading ...
Support Center